Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/7/2025

Shingles Vaccine Reaction Management

Types of Reactions and Their Management

  • Local swelling, redness, and pain at the injection site are common expected reactions that typically resolve spontaneously within 2-4 days 1
  • Fever is common after vaccination, with up to 70% of recipients experiencing temperatures >100°F for 4-14 days after primary vaccination 1
  • Regional lymph node swelling and tenderness may begin 3-10 days after vaccination and persist for 2-4 weeks 1
  • Nonspecific rashes (erythematous or urticarial) may occur approximately 10 days after vaccination and typically resolve within 2-4 days 2
  • Erythema multiforme (EM) may present as macules, papules, urticaria, or typical bull's-eye lesions and can be extremely pruritic 2
  • For EM reactions, oral antipruritic medications are beneficial, and the condition typically lasts less than 4 weeks 2
  • Stevens-Johnson syndrome, though rare, requires hospitalization and supportive care if it develops 2

Severe Reactions Requiring Medical Attention

  • Signs of anaphylaxis (difficulty breathing, facial swelling, severe urticaria) require emergency treatment with epinephrine 3
  • Development of vesicular rash beyond the injection site, which could indicate generalized vaccinia 4, 5
  • Symptoms of ocular involvement if vaccine virus has been transferred to the eye 4
  • For anaphylaxis: Place patient in recumbent position with legs elevated, administer aqueous epinephrine (1:1000), and arrange immediate transfer to an emergency facility 3
  • For suspected Stevens-Johnson syndrome: Consultation with specialists (dermatologists, immunologists, or infectious disease specialists) is recommended before administering systemic steroids 2

Special Considerations

  • Persons with a history of atopic dermatitis (eczema) are at higher risk for eczema vaccinatum and require close monitoring 4, 1
  • Immunocompromised individuals are at higher risk for progressive vaccinia and should generally not receive live vaccines 1
  • Pregnant women should avoid vaccinia vaccination due to risk of fetal vaccinia 1
  • Vaccinia can be transmitted from the vaccination site to other persons by close contact 4
  • Wash hands thoroughly with soap and warm water or use hand rubs containing >60% alcohol after touching the vaccination site 4, 1
  • Keep the vaccination site covered with a bandage until healing is complete 1